122 related articles for article (PubMed ID: 7624305)
1. The role of CCK and its analogues in the organogenesis of the fetal rat pancreas.
Feurle GE; Hamscher G; Firat AE
Pancreas; 1995 Apr; 10(3):281-6. PubMed ID: 7624305
[TBL] [Abstract][Full Text] [Related]
2. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
[TBL] [Abstract][Full Text] [Related]
3. Effects of cholecystokinin and gastrin antagonists on pancreatic exocrine secretion stimulated by gastrin-releasing peptide.
Terashima H; Debas HT; Bunnett NW
Pancreas; 1992; 7(2):212-9. PubMed ID: 1553370
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
[TBL] [Abstract][Full Text] [Related]
5. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
[TBL] [Abstract][Full Text] [Related]
6. Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor.
Ohlsson B; Axelson J; Sternby B; Rehfeld JF; Ihse I
Int J Pancreatol; 1995 Aug; 18(1):59-66. PubMed ID: 7594771
[TBL] [Abstract][Full Text] [Related]
7. Gastrin effects on growth and exocrine secretion in the neonatal rat pancreas.
Ballinger A; Ahmed M; Kumar P; Clark M
Pancreas; 1997 Apr; 14(3):295-300. PubMed ID: 9094162
[TBL] [Abstract][Full Text] [Related]
8. The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas.
Ohlsson B; Borg K; Rehfeld JF; Ihse I; Axelson J
Int J Pancreatol; 1998 Dec; 24(3):211-8. PubMed ID: 9873956
[TBL] [Abstract][Full Text] [Related]
9. Effects of endogenous and exogenous cholecystokinin and of infusion with the cholecystokinin antagonist L-364,718 on pancreatic and gastrointestinal growth.
Axelson J; Håkanson R; Ihse I; Lilja I; Rehfeld JF; Sundler F
Scand J Gastroenterol; 1990 May; 25(5):471-80. PubMed ID: 2359975
[TBL] [Abstract][Full Text] [Related]
10. Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas.
Ohlsson B; Borg K; Mulder H; Rehfeld JF; Axelson J; Sundler F
Scand J Gastroenterol; 2000 Jun; 35(6):612-8. PubMed ID: 10912661
[TBL] [Abstract][Full Text] [Related]
11. A new CCK-B/gastrin receptor antagonist acts as an agonist on the rat pancreas.
Koop I; Eissele R; Richter S; Patberg H; Meyer F; Mössner J; Arnold R; Koop H
Int J Pancreatol; 1994 Jun; 15(3):215-22. PubMed ID: 7523549
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.
Schmassmann A; Garner A; Flogerzi B; Hasan MY; Sanner M; Varga L; Halter F
Gut; 1994 Feb; 35(2):270-4. PubMed ID: 8307482
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin-A receptors.
Povoski SP; Zhou W; Longnecker DS; Jensen RT; Mantey SA; Bell RH
Gastroenterology; 1994 Oct; 107(4):1135-46. PubMed ID: 7523219
[TBL] [Abstract][Full Text] [Related]
14. The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines.
Ohlsson B; Fredäng N; Axelson J
Scand J Gastroenterol; 1999 Dec; 34(12):1224-9. PubMed ID: 10636070
[TBL] [Abstract][Full Text] [Related]
15. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals.
Zucker KA; Adrian TE; Bilchik AJ; Modlin IM
Am J Physiol; 1989 Oct; 257(4 Pt 1):G511-6. PubMed ID: 2478030
[TBL] [Abstract][Full Text] [Related]
16. Role of cholecystokinin, gastrin and gastrin-releasing peptide in the regulation of pancreatic secretion in cats.
Konturek SJ; Bilski J; Hladij M; Krzyzek E; Cai RZ; Schally AV
Digestion; 1991; 49(2):97-105. PubMed ID: 1724767
[TBL] [Abstract][Full Text] [Related]
17. Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs.
Konturek SJ; Tasler J; Konturek JW; Cieszkowski M; Szewczyk K; Hładij M; Anderson PS
Gut; 1989 Jan; 30(1):110-7. PubMed ID: 2920915
[TBL] [Abstract][Full Text] [Related]
18. Dose-related involvement of CCK in bombesin-induced pancreatic growth.
Liehr RM; Reidelberger RD; Rosewicz S; Bussjaeger LJ; Solomon TE
Regul Pept; 1992 Apr; 38(3):207-19. PubMed ID: 1375383
[TBL] [Abstract][Full Text] [Related]
19. Effects of a cholecystokinin receptor antagonist on rat exocrine pancreatic response to raw soya flour.
Sundaram S; Dayan AD
Hum Exp Toxicol; 1991 May; 10(3):179-82. PubMed ID: 1678946
[TBL] [Abstract][Full Text] [Related]
20. On the importance of cholecystokinin in neonatal pancreatic growth and secretory development in guinea pigs.
Herrington MK; Joekel CS; Vanderhoof JA; Adrian TE
Pancreas; 1995 Jul; 11(1):38-47. PubMed ID: 7545293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]